ATE137404T1 - Zusammensetzungen zur kontrollierten freigabe - Google Patents

Zusammensetzungen zur kontrollierten freigabe

Info

Publication number
ATE137404T1
ATE137404T1 AT91915434T AT91915434T ATE137404T1 AT E137404 T1 ATE137404 T1 AT E137404T1 AT 91915434 T AT91915434 T AT 91915434T AT 91915434 T AT91915434 T AT 91915434T AT E137404 T1 ATE137404 T1 AT E137404T1
Authority
AT
Austria
Prior art keywords
complex
active agent
composition
polycarbophil
polymeric
Prior art date
Application number
AT91915434T
Other languages
English (en)
Inventor
Ramesh N Acharya
Original Assignee
Theratech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/570,340 external-priority patent/US5110605A/en
Priority claimed from US07/580,854 external-priority patent/US5102666A/en
Priority claimed from US07/678,814 external-priority patent/US5686094A/en
Application filed by Theratech Inc filed Critical Theratech Inc
Application granted granted Critical
Publication of ATE137404T1 publication Critical patent/ATE137404T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/733—Alginic acid; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8147—Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8194—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, at least one having two or more carbon-to-carbon double bonds; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Lubricants (AREA)
AT91915434T 1990-08-21 1991-08-20 Zusammensetzungen zur kontrollierten freigabe ATE137404T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/570,340 US5110605A (en) 1990-08-21 1990-08-21 Calcium polycarbophil-alginate controlled release composition and method
US07/580,854 US5102666A (en) 1990-09-11 1990-09-11 Calcium polycarbophil controlled release composition and method
US07/678,814 US5686094A (en) 1991-04-01 1991-04-01 Controlled release formulations for the treatment of xerostomia

Publications (1)

Publication Number Publication Date
ATE137404T1 true ATE137404T1 (de) 1996-05-15

Family

ID=27416097

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91915434T ATE137404T1 (de) 1990-08-21 1991-08-20 Zusammensetzungen zur kontrollierten freigabe

Country Status (9)

Country Link
EP (1) EP0497956B1 (de)
JP (1) JP3064417B2 (de)
AT (1) ATE137404T1 (de)
AU (1) AU8444291A (de)
DE (1) DE69119217T2 (de)
DK (1) DK0497956T3 (de)
ES (1) ES2088500T3 (de)
GR (1) GR3020502T3 (de)
WO (1) WO1992003124A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5661171A (en) * 1992-07-02 1997-08-26 Oramed, Inc. Controlled release pilocarpine delivery system
EP0659077A1 (de) * 1992-07-02 1995-06-28 TheraTech, Inc. Pilocarpin-abgabesystem mit kontrollierter freisetzung
DE69330797T2 (de) * 1993-01-19 2002-05-23 The Gillette Co., Boston Mundwasser
US5885552A (en) * 1993-01-19 1999-03-23 Gillette Canada Inc. Mouthrinse
GB2279871B (en) * 1993-06-23 1997-05-07 Jevco Ltd Drug retention systems for use in aquaculture
US6548084B2 (en) 1995-07-20 2003-04-15 Smithkline Beecham Plc Controlled release compositions
GB9514842D0 (en) * 1995-07-20 1995-09-20 Smithkline Beecham Plc Novel formulation
AU748804B2 (en) * 1995-07-20 2002-06-13 Smithkline Beecham Plc Paroxetine controlled release compositions
US5912007A (en) * 1996-02-29 1999-06-15 Warner-Lambert Company Delivery system for the localized administration of medicaments to the upper respiratory tract and methods for preparing and using same
IT1284874B1 (it) * 1996-08-02 1998-05-22 Farmigea Spa Complessi bioadesivi di polycarbophil e farmaci antifungini o antiprotozoari azolici
DE19637792A1 (de) * 1996-09-17 1998-03-19 Huels Chemische Werke Ag Katalysator und Verfahren zur katalytischen Abgasreinigung im DMT-Prozeß
JP4850709B2 (ja) * 2003-05-14 2012-01-11 ダニスコ・ユーエス・インコーポレーテッド 反復配列タンパク質ポリマーを使用する、活性剤の制御放出
ES2344911T3 (es) 2004-08-02 2010-09-09 Glaxo Group Limited Composicion novedosa para tratar la xerostomia.
US20060045865A1 (en) * 2004-08-27 2006-03-02 Spherics, Inc. Controlled regional oral delivery
WO2007017712A1 (en) * 2005-08-11 2007-02-15 Promedon Do Brasil Produtos Medico-Hospitalares Ltda. Composition comprising polymeric, water-insoluble, anionic particles, processes and uses
TW201010743A (en) * 2008-09-05 2010-03-16 Otsuka Pharma Co Ltd Pharmaceutical solid preparation
EP3145548B1 (de) 2014-05-22 2022-04-13 University of Copenhagen Wässrige gel-zusammensetzung und ihre verwendung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0830004B2 (ja) * 1983-11-14 1996-03-27 コロンビア ラボラトリーズ インコーポレイテッド 生物接着性組成物およびそれにより治療する方法
IE63392B1 (en) * 1988-02-08 1995-04-19 Insite Vision Inc Ophthalmic suspensions
CA2003808C (en) * 1988-11-28 1999-11-09 Eugene Joseph Sehm Crosslinked polyacrylic acid
US4988679A (en) * 1989-01-03 1991-01-29 Leonard Chavkin Liquid sustained release composition
HU227563B1 (en) * 1989-10-31 2011-08-29 Columbia Lab Bermuda Ltd Process for production of composition for moisturizing of tissue

Also Published As

Publication number Publication date
DK0497956T3 (da) 1996-08-12
JPH05502894A (ja) 1993-05-20
EP0497956A1 (de) 1992-08-12
ES2088500T3 (es) 1996-08-16
GR3020502T3 (en) 1996-10-31
JP3064417B2 (ja) 2000-07-12
EP0497956A4 (en) 1993-03-31
EP0497956B1 (de) 1996-05-01
WO1992003124A1 (en) 1992-03-05
DE69119217D1 (de) 1996-06-05
AU8444291A (en) 1992-03-17
DE69119217T2 (de) 1996-10-31

Similar Documents

Publication Publication Date Title
DE69119217D1 (de) Zusammensetzungen zur kontrollierten freigabe
ES8701390A1 (es) Un procedimiento para tratar lentes de contacto.
MX9306239A (es) Composicion farmaceutica que forma un gel de lecitina in vivo para la liberacion mantenida de un compuesto biologicamente activo y procedimiento para la preparacion de la misma.
DE59209658D1 (de) Pharmazeutische zusammensetzung zur wund-, narben- und keloidbehandlung
DE69736745D1 (de) Verfahren zur behandlung von prostaterkrankungen unter verwendung von vitamin-d-formulierungen mit verzögerter und/oder verlängerter wirkstofffreigabe
ATE151282T1 (de) Zusammensetzungen mit verzögerter wirkstoffabgabe zur behandlung periodontaler erkrankungen
ATE202923T1 (de) Orale dosierungsform und verfahren zur behandlung von schmerzzuständen in dermundhöhle
UA41989C2 (uk) Фармацевтична композиція у вигляді гелю для лікування захворювань шкіри та спосіб лікування інфікованої шкіри
ATE209907T1 (de) Flüssige mittel zur wirkstoffabgabe
DE69615400D1 (de) 5-asa enthaltendes orales arzneimittel mit modifizierter freisetzung sowie verfahren zur behandlung von darmerkrankungen
DE69025271D1 (de) Pharmazeutische Zubereitungen mit verzögerter Freisetzung zur Behandlung periodontaler Erkrankungen
DE59002748D1 (de) Verfahren zur Herstellung von Mitteln zur Therapie von Hauterkrankungen.
DE59600683D1 (de) Verwendung von Trospiumchlorid zur Herstellung eines Arzneimittels zur Behandlung von Blasenkrankheiten
DE69633393D1 (de) Mitteln zur behandlung von auto-immun krankheiten
NZ506681A (en) Disinfecting composition
JPS6434916A (en) Medicinal composition for treating uremia
ATE7107T1 (de) Mittel zur behandlung von colitis ulcerosa, enteritis regionalis crohn (morbus crohn), chronischer unspezifischer colitis und divertikulitis sowie verwendung von salicylazobenzoesaeure, zur herstellung von derartigen mitteln.
ATE371441T1 (de) Verfahren zur herstellung einer pharmazeutischen zubereitung mit 5-aminosalicylsäure zur verwendung bei der behandlung von colitis ulcerosa und morbus crohn
ATE173639T1 (de) Wasserstoffperoxid zersetzende zusammensetzungen und verfahren zur herstellung und verwendung derselben
DE69004425D1 (de) Verwendung von c-20 bis c-26-aliphatischen alkoholen zur herstellung eines arzneimittels zur behandlung viraler infektionen.
ATE86112T1 (de) Pharmazeutische zubereitung zur behandlung entzuendeter nasenschleimhaeute.
DE69511453D1 (de) Verwendung einer Kombination von Antineoplastonen zur Herstellung eines Arzneimittels zur Behandlung der Neurofibromatose
US4250167A (en) Methods for reducing calcium deposits
CN116803408A (zh) 一种抑制性功能障碍配方
ATE28384T1 (de) Medizinisches verfahren und zubereitung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee